Skip to content
StimCell_logo
  • About Us
    • The Company
    • Our Goal
    • Management
  • The Science
    • Microcurrents
    • Clinical Studies
  • The Product
    • eBalance
    • Bio Feedback
  • Clinical Trials
    • Trial Results
  • Investors
    • Stock Quote
    • News
    • SEC Filings
  • Contact us
StimCell_logo

Tag: clinical trial

May 26, 2021 corporate

Cell MedX Corp. Converts Debt to Shares, Closes Non-brokered Private Placement Financing, and Engages Investor Relations Consultants

Carson City, Nevada, May 26, 2020, Cell MedX Corp. (OTCQB: CMXC, 9CX:MUN) (“Cell MedX” or the “Company”), a biotech company focusing on the discovery, development and commercialization of therapeutic and non-therapeutic products that promote general health and wellness, is pleased…

Continue
September 24, 2020 corporate

Cell MedX Corp. Signs Extension Agreement with Think Ink Marketing

Carson City, Nevada, September 24, 2020, Cell MedX Corp. (OTCQB: CMXC, 9CX:MUN) (“Cell MedX” or the “Company”), a biotech company focusing on the discovery, development and commercialization of therapeutic and non-therapeutic products that promote general health and wellness, announced today…

Continue
September 1, 2020 corporate

Cell MedX Corp.’s eBalance Pro System Receives Class II Medical Device License from Health Canada

Carson City, Nevada, September 1, 2020, Cell MedX Corp. (OTCQB: CMXC, 9CX:MUN) (“Cell MedX” or the “Company”), a bio-tech company focusing on the discovery, development and commercialization of therapeutic and non-therapeutic products that promote general health and wellness, is happy…

Continue
August 4, 2020 corporate

Cell MedX Corp. (CMXC) Closes Non-Brokered Private Placement Financing

Carson City, Nevada, August 4, 2020, Cell MedX Corp. (OTCQB: CMXC, 9CX:MUN) (“Cell MedX” or the “Company”), a bio-tech company focusing on the discovery, development and commercialization of therapeutic and non-therapeutic products that promote general health and wellness, is pleased…

Continue
July 22, 2020 corporate

Cell MedX Corp.’s eBalance Home System Receives Class II Medical Device License from Health Canada

Carson City, Nevada, July 22, 2020, Cell MedX Corp. (OTCQB: CMXC, 9CX:MUN) (“Cell MedX” or the “Company”), a bio-tech company focusing on the discovery, development and commercialization of therapeutic and non-therapeutic products that promote general health and wellness, is happy to…

Continue
July 7, 2020 corporate

Cell MedX Corp. Files Two Applications for Class II Medical Device Licenses with Health Canada

Carson City, Nevada, July 7, 2020, Cell MedX Corp. (OTCQB: CMXC, 9CX:MUN) (“Cell MedX” or the “Company”), a bio-tech company focusing on the discovery, development and commercialization of therapeutic and non-therapeutic products that promote general wellness, announced today that the Company…

Continue
June 9, 2020 corporate

Cell MedX Corp. Receives Quality Management System ISO 13485:2016 MDSAP Certificate

Carson City, Nevada, June 9, 2020, Cell MedX Corp. (OTCQB: CMXC, 9CX:MUN) (“Cell MedX” or the “Company”), a bio-tech company focusing on the discovery, development and commercialization of therapeutic and non-therapeutic products that promote general wellness, announced today that the Company…

Continue
April 17, 2020 corporate

Cell MedX Corp. Announces a Non-Brokered Private Placement Financing

Carson City, Nevada, April 17, 2020, Cell MedX Corp. (OTCQB: CMXC, 9CX:MUN) (“Cell MedX” or the “Company”), a biotech company focusing on the discovery, development and commercialization of therapeutic and non-therapeutic products that promote general wellness, announced today that the Company…

Continue
April 7, 2020 corporate

Cell MedX Corp. Receives Quality Management System ISO 13485:2016 Certificate for the eBalance® Device

Carson City, Nevada, April 7, 2020, Cell MedX Corp. (OTCQB: CMXC, 9CX:MUN) (“Cell MedX” or the “Company”), an early development stage bio-tech company focusing on the discovery, development and commercialization of therapeutic and non-therapeutic products that promote general wellness, announced today…

Continue
January 30, 2020 corporate

Cell MedX Corp. Reacquires World Wide Exclusivity Rights for the eBalanceⓇ Device

Carson City, Nevada, January 30, 2020, Cell MedX Corp. (OTCQB: CMXC, 9CX:MUN) (“Cell MedX” or the “Company”), a biotech company focusing on the discovery, development and commercialization of therapeutic and non-therapeutic products that promote general wellness, is pleased to announce that…

Continue
  • 1
  • 2
  • 3
  • 4
  • 5

Categories

  • corporate
  • media

Archives

  • September 2026
  • March 2026
  • December 2025
  • October 2025
  • March 2025
  • February 2025
  • January 2025
  • November 2024
  • March 2024
  • February 2024
  • December 2023
  • November 2023
  • October 2022
  • September 2022
  • June 2022
  • April 2022
  • March 2022
  • November 2021
  • September 2021
  • May 2021
  • September 2020
  • August 2020
  • July 2020
  • June 2020
  • April 2020
  • January 2020
  • December 2019
  • October 2019
  • September 2019
  • August 2019
  • June 2019
  • May 2019
  • March 2019
  • February 2019
  • December 2018
  • September 2018
  • May 2018
  • March 2018
  • January 2018
  • December 2017
  • August 2017
  • July 2017
  • April 2017
  • March 2017
  • February 2017
  • January 2017
  • December 2016
  • November 2016
  • October 2016
  • September 2016
  • July 2016
  • March 2016
  • January 2016
  • October 2015
  • September 2015
  • August 2015
  • July 2015
  • June 2015
  • April 2015
  • February 2015
  • January 2015
  • December 2014
  • November 2014
  • October 2014

Meta

  • Log in
  • Entries feed
  • Comments feed
  • WordPress.org

Popular Tags

atp clinical trial diabetes eBalance electron transport chain mitochondria observational trial protein synthesis stimcell study university

Company

  • The Company
  • Our Goal
  • Management

Product

  • eBalance
  • BioFeedback
  • Clinical Trial Results

Investors

  • Stock Quote
  • News
  • SEC Filings

Contact

  • info@stimcell.com
  • 1-866-347-5056

© 2025 StimCell Energetics — All Rights Reserved